Ever Supreme Bio Technology Co., Ltd - Laporan Laba Rugi (TTM)

Ever Supreme Bio Technology Co., Ltd
TW ˙ TPEX
NT$ 184.50 ↑1.50 (0.82%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Ever Supreme Bio Technology Co., Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 53 71 112 193 310 439 513 575 603 628 621 628 683 758 805 824 845 934 948 991
Change (%) 32.43 58.40 72.82 60.32 41.64 16.98 12.00 4.86 4.09 -1.05 1.14 8.79 11.01 6.13 2.33 2.59 10.53 1.56 4.49
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 65 89 114 137 169 193 204 224 215 213 232 233 241 274 246 247 253 274 288 287
Change (%) 35.25 28.81 20.52 22.95 14.42 5.63 9.52 -3.76 -1.09 9.17 0.33 3.49 13.36 -10.06 0.24 2.70 8.05 5.31 -0.40
% of Revenue 122.80 125.42 101.99 71.12 54.54 44.06 39.79 38.91 35.71 33.94 37.44 37.14 35.33 36.08 30.58 29.96 29.99 29.32 30.40 28.98
Gross Operating Profit -12 -18 -2 56 141 245 309 351 388 415 388 395 442 485 559 577 591 660 660 704
Change (%) 47.62 -87.63 -2,613.87 152.35 74.30 25.91 13.63 10.35 6.97 -6.31 1.63 11.92 9.73 15.26 3.25 2.54 11.59 0.01 6.62
% of Revenue -22.80 -25.42 -1.99 28.88 45.46 55.94 60.21 61.09 64.29 66.06 62.56 62.86 64.67 63.92 69.42 70.04 70.01 70.68 69.60 71.02
SG&A 42 30 35 36 39 45 43 45 45 40 40 41 45 48 49 49 46 47 47 46
Change (%) -28.25 17.99 1.26 8.87 16.01 -5.16 4.77 0.25 -10.88 -0.91 2.35 10.82 6.38 2.72 -1.33 -5.63 3.09 0.53 -2.52
% of Revenue 78.21 42.37 31.56 18.49 12.56 10.29 8.34 7.80 7.46 6.39 6.39 6.47 6.59 6.32 6.11 5.90 5.42 5.06 5.01 4.67
R&D 119 109 100 90 79 84 87 85 97 91 90 95 95 99 101 103 122 147 176 195
Change (%) -7.94 -8.45 -10.10 -11.99 6.32 3.00 -1.62 13.22 -6.05 -0.48 5.24 -0.20 4.54 1.50 2.52 18.53 20.43 19.39 10.90
% of Revenue 222.60 154.75 89.44 46.53 25.54 19.17 16.88 14.83 16.01 14.45 14.54 15.13 13.88 13.07 12.50 12.52 14.47 15.77 18.53 19.67
OpEx 226 228 249 263 287 323 334 354 357 344 362 369 381 421 419 421 466 513 533 550
Change (%) 0.83 9.51 5.51 9.10 12.40 3.44 6.02 0.84 -3.67 5.45 1.77 3.35 10.34 -0.43 0.59 10.57 10.04 3.98 3.15
% of Revenue 423.62 322.54 222.99 136.14 92.65 73.52 65.01 61.54 59.18 54.77 58.38 58.74 55.80 55.47 52.04 51.16 55.14 54.90 56.20 55.49
Operating Income -173 -157 -138 -70 23 116 180 221 246 284 258 259 302 338 386 402 379 421 415 441
Change (%) -8.93 -12.46 -49.21 -132.62 409.97 54.56 23.10 11.29 15.33 -8.93 0.25 16.53 11.86 14.29 4.21 -5.78 11.12 -1.38 6.20
% of Revenue -323.62 -222.54 -122.99 -36.14 7.35 26.48 34.99 38.46 40.82 45.23 41.62 41.26 44.20 44.53 47.96 48.84 44.86 45.10 43.80 44.51
Interest Expense -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1
Change (%) 4.57 -2.44 -3.43 -10.91 -5.36 -4.69 -3.23 -4.39 -6.42 -14.51 -18.12 -22.13 -27.70 -10.45 -13.33 -8.97 -11.97 117.60 129.78
% of Revenue -1.40 -1.10 -0.68 -0.38 -0.21 -0.14 -0.11 -0.10 -0.09 -0.08 -0.07 -0.06 -0.04 -0.03 -0.02 -0.02 -0.02 -0.01 -0.03 -0.06
Net Income -118 -107 -94 15 261 370 374 348 153 201 326 335 571 539 446 511 254 367 434 408
Change (%) -9.76 -11.81 -115.45 1,694.19 41.55 1.13 -6.99 -56.08 31.46 62.24 2.82 70.69 -5.61 -17.33 14.53 -50.20 44.40 18.07 -5.93
% of Revenue -222.07 -151.32 -84.25 7.53 84.27 84.22 72.81 60.47 25.33 31.99 52.45 53.31 83.65 71.12 55.40 62.01 30.10 39.33 45.72 41.16

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista